Delivery Order SPE2DB24D9144-SPE2DB24FCMKW

Award Date 9/4/24
Potential Completion Date 9/5/24
Potential Value $12K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,840.66 contract is for the delivery of JAKAFI 10 MG TABLET 60S, with a completion date of July 12, 2024. DMS Pharmaceutical Group holds a significant $499,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program, which allows the agency to issue firm...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,840.66 contract is for the delivery of JAKAFI 10 MG TABLET 60S, a specialized prescription medication. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program, which...
The U.S. government agency Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $11,840.66 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the delivery of the pharmaceutical product JAKAFI 10 MG TABLET 60S. This delivery order is issued under DMS Pharmaceutical Group's $499,999,999 single-award indefinite delivery contract (IDC) with the DLA under the SPE2DB program. The...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $12,115.65 firm fixed-price contract is for the delivery of JAKAFI 10 MG TABLET 60S, a specialized pharmaceutical product, with a period of performance through April 2, 2025. DMS Pharmaceutical Group Inc. holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $11,840.66 contract is for the delivery of JAKAFI 10 MG TABLET 60S, a pharmaceutical product, with a completion date of March 6, 2024. The contract has no set-aside designation. DMS Pharmaceutical Group Inc. holds a separate $4,999,999 indefinite delivery contract (IDC) with the DLA under the SPE2DB program,...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $11,840.66, is for a firm fixed-price delivery order for the supply of 4564977253 JAKAFI 10 MG TABLET 60S, a pharmaceutical product. The contract has an ultimate completion date of June 24, 2024 and was awarded on June 21, 2024. It is not associated with a set-aside designation. DMS...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,840.66 firm fixed-price contract is for the supply of JAKAFI 10 MG TABLET 60S, a prescription medication. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which provides...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,840.66 contract is for the delivery of the prescription drug JAKAFI 10 MG TABLET 60S. This order is issued under a larger, single-award indefinite delivery contract (IDC) valued at up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The award, valued at $11,840.66, is for the delivery of JAKAFI 10 MG TABLET 60S, a prescription medication. The contract is a firm fixed-price delivery order with no set-aside designation. It has an ultimate completion date of September 26, 2024. DMS Pharmaceutical Group holds a larger indefinite...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $11,794.12, is for the delivery of JAKAFI 20 MG TABLET 60S, a specialized pharmaceutical product. The delivery order was awarded under DMS Pharmaceutical Group's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $499,999,999 and valid through...
  • SPE2DB24D9144
    Indefinite Delivery Contract
  • SPE2DB24D9144-SPE2DB24FCMKW
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $11,840.66 firm fixed-price contract is for the supply of JAKAFI 10 MG TABLET 60S, a pharmaceutical product, with a period of performance through September 5, 2024. This award is under DMS Pharmaceutical Group's larger $499,999,999 indefinite delivery contract with the DLA, which covers a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. The contract does not have a set-aside designation.

Generated 12/4/24, 10:09 AM